Oxidized high-density lipoprotein impairs endothelial progenitor cells' function by activation of CD36-MAPK-TSP-1 pathways

Antioxidants and Redox Signaling

Volumn 22, Issue 4, 2015, Pages 308-324

  Wu, Jianxiang ^a,b   He, Zhiqing ^a   Gao, Xiang ^a   Wu, Feng ^a,c   Ding, Ru ^a   Ren, Yusheng ^a   Jiang, Qijun ^a   Fan, Min ^a   Liang, Chun ^a   Wu, Zonggui ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b No 411 Hospital of PLA   (China)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CD36 ANTIGEN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; OXIDIZED HIGH DENSITY LIPOPROTEIN; PROBUCOL; REACTIVE OXYGEN METABOLITE; SHORT HAIRPIN RNA; THROMBOSPONDIN 1; UNCLASSIFIED DRUG; VASCULOTROPIN; BASIC HELIX LOOP HELIX LEUCINE ZIPPER TRANSCRIPTION FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SPZ1 PROTEIN, HUMAN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADULT; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL FUNCTION; CELL MIGRATION; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATIONAL STUDY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL PROGENITOR CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; IN VIVO STUDY; LIPID OXIDATION; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; ANIMAL; BLOOD; CASE CONTROL STUDY; CELL CULTURE; CELL MOTION; GENE EXPRESSION; GENETICS; HINDLIMB; METABOLISM; MIDDLE AGED; NUDE MOUSE; OXIDATION REDUCTION REACTION; PHYSIOLOGY; SECRETION (PROCESS); VASCULARIZATION;

ANIMALS; ANTIGENS, CD36; APOPTOSIS; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; CASE-CONTROL STUDIES; CELL MOVEMENT; CELLS, CULTURED; CHOLESTEROL; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; ENDOTHELIAL PROGENITOR CELLS; FEMALE; GENE EXPRESSION; HINDLIMB; HUMANS; LIPOPROTEINS, HDL; MALE; MAP KINASE SIGNALING SYSTEM; MICE, NUDE; MIDDLE AGED; NEOVASCULARIZATION, PHYSIOLOGIC; NF-KAPPA B; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84921407891     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2013.5743     Document Type: Article

References (75)

1. Ahrens I, Domeij H, Eisenhardt SU, Topcic D, Albrecht M, Leitner E, Viitaniemi K, Jowett JB, Lappas M, Bode C, Haviv I, and Peter K. Opposing effects of monomeric and pentameric C-reactive protein on endothelial progenitor cells. Basic Res Cardiol 106: 879-895, 2011.
2. Al Gadban MM, Smith KJ, Soodavar F, Piansay C, Chassereau C, Twal WO, Klein RL, Virella G, Lopes-Virella MF, and Hammad SM. Differential trafficking of oxidized LDL and oxidized LDL immune complexes in macrophages: impact on oxidative stress. PLoS One 5: e12534, 2010.
3. Assinger A, Schmid W, Eder S, Schmid D, Koller E, and Volf I. Oxidation by hypochlorite converts protective HDL into a potent platelet agonist. FEBS Lett 582: 778-784, 2008.
4. Bai H, Liu BW, Deng ZY, Shen T, Fang DZ, Zhao YH, and Liu Y. Plasma very-low-density lipoprotein, low-density lipoprotein, and high-density lipoprotein oxidative modification induces procoagulant profiles in endogenous hypertriglyceridemia. Free Radic Biol Med 40: 1796-1803, 2006.
5. Barter P, Gotto AM, LaRosa JC, Maroni J, Szarek M, Grundy SM, Kastelein JJ, Bittner V, and Fruchart JC. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J Med 357: 1301-1310, 2007.
6. Barter PJ, Nicholls S, Rye KA, Anantharamaiah GM, Navab M, and Fogelman AM. Antiinflammatory properties of HDL. Circ Res 95: 764-772, 2004.
7. Bujold K, Rhainds D, Jossart C, Febbraio M, Marleau S, and Ong H. CD36-mediated cholesterol efflux is associated with PPARgamma activation via a MAPK-dependent COX-2 pathway in macrophages. Cardiovasc Res 83: 457-464, 2009.
8. Carbonneau MA, Peuchant E, Sess D, Canioni P, and Clerc M. Free and bound malondialdehyde measured as thiobarbituric acid adduct by HPLC in serum and plasma. Clin Chem 37: 1423-1429, 1991.
9. Chu LY, Ramakrishnan DP, and Silverstein RL. Thrombospondin-1 modulates VEGF signaling via CD36 by recruiting SHP-1 to VEGFR2 complex in microvascular endothelial cells. Blood 122: 1822-1832, 2013.
10. Diez M, Musri MM, Ferrer E, Barbera JA, and Peinado VI. Endothelial progenitor cells undergo an endothelial-tomesenchymal transition-like process mediated by TGFbetaRI. Cardiovasc Res 88: 502-511, 2010.
11. Fadini GP, Sartore S, Albiero M, Baesso I, Murphy E, Menegolo M, Grego F, Vigili de Kreutzenberg S, Tiengo A, Agostini C, and Avogaro A. Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy. Arterioscler Thromb Vasc Biol 26: 2140-2146, 2006.
12. Febbraio M, Hajjar DP, and Silverstein RL. CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J Clin Invest 108: 785-791, 2001.
13. Ferretti G, Bacchetti T, Negre-Salvayre A, Salvayre R, Dousset N, and Curatola G. Structural modifications of HDL and functional consequences. Atherosclerosis 184: 1-7, 2006.
14. Foubert P, Silvestre JS, Souttou B, Barateau V, Martin C, Ebrahimian TG, Lere-Dean C, Contreres JO, Sulpice E, Levy BI, Plouet J, Tobelem G, and Le Ricousse-Roussanne S. PSGL-1-mediated activation of EphB4 increases the proangiogenic potential of endothelial progenitor cells. J Clin Invest 117: 1527-1537, 2007.
15. Francis GA. High density lipoprotein oxidation: in vitro susceptibility and potential in vivo consequences. Biochim Biophys Acta 1483: 217-235, 2000.
16. Girona J, LaVille AE, Sola R, Motta C, and Masana L. HDL derived from the different phases of conjugated diene formation reduces membrane fluidity and contributes to a decrease in free cholesterol efflux from human THP-1 macrophages. Biochim Biophys Acta 1633: 143-148, 2003.
17. Gordon SM, Deng J, Lu LJ, and Davidson WS. Proteomic characterization of human plasma high density lipoprotein fractionated by gel filtration chromatography. J Proteome Res 9: 5239-5249, 2010.
18. Hale JS, Li M, Sinyuk M, Jahnen-Dechent W, Lathia JD, and Silverstein RL. Context dependent role of the CD36-thrombospondin-histidine-rich glycoprotein axis in tumor angiogenesis and growth. PLoS One 7: e40033, 2012.
19. Hamed S, Brenner B, Aharon A, Daoud D, and Roguin A. Nitric oxide and superoxide dismutase modulate endothelial progenitor cell function in type 2 diabetes mellitus. Cardiovasc Diabetol 8: 56, 2009.
20. Hofmann NA, Reinisch A, and Strunk D. Isolation and large scale expansion of adult human endothelial colony forming progenitor cells. J Vis Exp 1524, 2009.
21. Hofmann NA, Reinisch A, and Strunk D. Endothelial colony-forming progenitor cell isolation and expansion. Methods Mol Biol 879: 381-387, 2012.
22. Honma T, Tsuduki T, Sugawara S, Kitano Y, Ito J, Kijima R, Tsubata M, Nakagawa K, and Miyazawa T. Aging decreases antioxidant effects and increases lipid peroxidation in the Apolipoprotein E deficient mouse. J Clin Biochem Nutr 52: 234-240, 2013.
23. Huang CY, Lin FY, Shih CM, Au HK, Chang YJ, Nakagami H, Morishita R, Chang NC, Shyu KG, and Chen JW. Moderate to high concentrations of high-density lipoprotein from healthy subjects paradoxically impair human endothelial progenitor cells and related angiogenesis by activating Rho-associated kinase pathways. Arterioscler Thromb Vasc Biol 32: 2405-2417, 2012.
24. Hui SP, Taguchi Y, Takeda S, Ohkawa F, Sakurai T, Yamaki S, Jin S, Fuda H, Kurosawa T, and Chiba H. Quantitative determination of phosphatidylcholine hydroperoxides during copper oxidation of LDL and HDL by liquid chromatography/mass spectrometry. Anal Bioanal Chem 403: 1831-1840, 2012.
25. Huq MD, Gupta P, Tsai NP, and Wei LN. Modulation of testicular receptor 4 activity by mitogen-activated protein kinase-mediated phosphorylation. Mol Cell Proteomics 5: 2072-2082, 2006.
26. Jeong JO, Kim MO, Kim H, Lee MY, Kim SW, Ii M, Lee JU, Lee J, Choi YJ, Cho HJ, Lee N, Silver M, Wecker A, Kim DW, and Yoon YS. Dual angiogenic and neurotrophic effects of bone marrow-derived endothelial progenitor cells on diabetic neuropathy. Circulation 119: 699-708, 2009.
27. Jiang H, Liang C, Liu X, Jiang Q, He Z, Wu J, Pan X, Ren Y, Fan M, Li M, and Wu Z. Palmitic acid promotes endothelial progenitor cells apoptosis via p38 and JNK mitogen-activated protein kinase pathways. Atherosclerosis 210: 71-77, 2010.
28. Jimenez B, Volpert OV, Crawford SE, Febbraio M, Silverstein RL, and Bouck N. Signals leading to apoptosisdependent inhibition of neovascularization by thrombospondin-1. Nat Med 6: 41-48, 2000.
29. Juliet PA, Hayashi T, Iguchi A, and Ignarro LJ. Concomitant production of nitric oxide and superoxide in human macrophages. Biochem Biophys Res Commun 310: 367-370, 2003.
30. Kashyap SR, Ioachimescu AG, Gornik HL, Gopan T, Davidson MB, Makdissi A, Major J, Febbraio M, and Silverstein RL. Lipid-induced insulin resistance is associated with increased monocyte expression of scavenger receptor CD36 and internalization of oxidized LDL. Obesity (Silver Spring) 17: 2142-2148, 2009.
31. Kaur S, Kumar TR, Uruno A, Sugawara A, Jayakumar K, and Kartha CC. Genetic engineering with endothelial nitric oxide synthase improves functional properties of endothelial progenitor cells from patients with coronary artery disease: an in vitro study. Basic Res Cardiol 104: 739-749, 2009.
32. Khaidakov M, Mitra S, Wang X, Ding Z, Bora N, Lyzogubov V, Romeo F, Schichman SA, and Mehta JL. Large impact of low concentration oxidized LDL on angiogenic potential of human endothelial cells: a microarray study. PLoS One 7: e47421, 2012.
33. Kim HM, Kim KJ, Moon JH, Lee HJ, Chae MK, Chang HJ, Kang ES, Cha BS, Lee HC, Kim YJ, and Lee BW. Association between EPCs count and rate of coronary revascularization in asymptomatic type 2 diabetic patients. Acta Diabetol 49: 413-420, 2012.
34. Kontush A, de Faria EC, Chantepie S, and Chapman MJ. Antioxidative activity of HDL particle subspecies is impaired in hyperalphalipoproteinemia: relevance of enzymatic and physicochemical properties. Arterioscler Thromb Vasc Biol 24: 526-533, 2004.
35. Li W, Febbraio M, Reddy SP, Yu DY, Yamamoto M, and Silverstein RL. CD36 participates in a signaling pathway that regulates ROS formation in murine VSMCs. J Clin Invest 120: 3996-4006, 2010.
36. Liu Q, Xi Y, Terry T, So SP, Mohite A, Zhang J, Wu G, Liu X, Cheng J, Ruan KH, Willerson JT, and Dixon RA. Engineered endothelial progenitor cells that overexpress prostacyclin protect vascular cells. J Cell Physiol 227: 2907-2916, 2012.
37. Liu ZJ and Velazquez OC. Hyperoxia, endothelial progenitor cell mobilization, and diabetic wound healing. Antioxid Redox Signal 10: 1869-1882, 2008.
38. Marsche G, Furtmuller PG, Obinger C, Sattler W, and Malle E. Hypochlorite-modified high-density lipoprotein acts as a sink for myeloperoxidase in vitro. Cardiovasc Res 79: 187-194, 2008.
39. Matsunaga T, Hokari S, Koyama I, Harada T, and Komoda T. NF-kappa B activation in endothelial cells treated with oxidized high-density lipoprotein. Biochem Biophys Res Commun 303: 313-319, 2003.
40. Mattern HM, Raikar LS, and Hardin CD. The effect of caveolin-1 (Cav-1) on fatty acid uptake and CD36 localization and lipotoxicity in vascular smooth muscle (VSM) cells. Int J Physiol Pathophysiol Pharmacol 1: 1-14, 2009.
41. Melero-Martin JM, De Obaldia ME, Kang SY, Khan ZA, Yuan L, Oettgen P, and Bischoff J. Engineering robust and functional vascular networks in vivo with human adult and cord blood-derived progenitor cells. Circ Res 103: 194-202, 2008.
42. Mineo C and Shaul PW. Role of high-density lipoprotein and scavenger receptor B type I in the promotion of endothelial repair. Trends Cardiovasc Med 17: 156-161, 2007.
43. Mineo C and Shaul PW. PON-dering differences in HDL function in coronary artery disease. J Clin Invest 121: 2545-2548, 2011.
44. Mitsutake S, Zama K, Yokota H, Yoshida T, Tanaka M, Mitsui M, Ikawa M, Okabe M, Tanaka Y, Yamashita T, Takemoto H, Okazaki T, Watanabe K, and Igarashi Y. Dynamic modification of sphingomyelin in lipid microdomains controls development of obesity, fatty liver, and type 2 diabetes. J Biol Chem 286: 28544-28555, 2011.
45. Nagano Y, Arai H, and Kita T. High density lipoprotein loses its effect to stimulate efflux of cholesterol from foam cells after oxidative modification. Proc Natl Acad Sci USA 88: 6457-6461, 1991.
46. Nuszkowski A, Grabner R, Marsche G, Unbehaun A, Malle E, and Heller R. Hypochlorite-modified low density lipoprotein inhibits nitric oxide synthesis in endothelial cells via an intracellular dislocalization of endothelial nitricoxide synthase. J Biol Chem 276: 14212-14221, 2001.
47. Podrez EA, Poliakov E, Shen Z, Zhang R, Deng Y, Sun M, Finton PJ, Shan L, Gugiu B, Fox PL, Hoff HF, Salomon RG, and Hazen SL. Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36. J Biol Chem 277: 38503-38516, 2002.
48. Primo L, Ferrandi C, Roca C, Marchio S, di Blasio L, Alessio M, and Bussolino F. Identification of CD36 molecular features required for its in vitro angiostatic activity. FASEB J 19: 1713-1715, 2005.
49. Reinisch A, Hofmann NA, Obenauf AC, Kashofer K, Rohde E, Schallmoser K, Flicker K, Lanzer G, Linkesch W, Speicher MR, and Strunk D. Humanized large-scale expanded endothelial colony-forming cells function in vitro and in vivo. Blood 113: 6716-6725, 2009.
50. Saddar S, Mineo C, and Shaul PW. Signaling by the highaffinity HDL receptor scavenger receptor B type I. Arterioscler Thromb Vasc Biol 30: 144-150, 2010.
51. Sata M. Role of circulating vascular progenitors in angiogenesis, vascular healing, and pulmonary hypertension: lessons from animal models. Arterioscler Thromb Vasc Biol 26: 1008-1014, 2006.
52. Schmidt-Lucke C, Fichtlscherer S, Aicher A, Tschope C, Schultheiss HP, Zeiher AM, and Dimmeler S. Quantification of circulating endothelial progenitor cells using the modified ISHAGE protocol. PLoS One 5: e13790, 2010.
53. Shao B, Pennathur S, Pagani I, Oda MN, Witztum JL, Oram JF, and Heinecke JW. Modifying apolipoprotein A-I by malondialdehyde, but not by an array of other reactive carbonyls, blocks cholesterol efflux by the ABCA1 pathway. J Biol Chem 285: 18473-18484, 2010.
54. Shilo S, Roy S, Khanna S, and Sen CK. Evidence for the involvement of miRNA in redox regulated angiogenic response of human microvascular endothelial cells. Arterioscler Thromb Vasc Biol 28: 471-477, 2008.
55. Sirpal S. Myeloperoxidase-mediated lipoprotein carbamylation as a mechanistic pathway for atherosclerotic vascular disease. Clin Sci (Lond) 116: 681-695, 2009.
56. Sorrentino SA, Besler C, Rohrer L, Meyer M, Heinrich K, Bahlmann FH, Mueller M, Horvath T, Doerries C, Heinemann M, Flemmer S, Markowski A, Manes C, Bahr MJ, Haller H, von Eckardstein A, Drexler H, and Landmesser U. Endothelial-vasoprotective effects of highdensity lipoprotein are impaired in patients with type 2 diabetes mellitus but are improved after extended-release niacin therapy. Circulation 121: 110-122, 2010.
57. Stewart CR, Stuart LM, Wilkinson K, van Gils JM, Deng J, Halle A, Rayner KJ, Boyer L, Zhong R, Frazier WA, Lacy-Hulbert A, El Khoury J, Golenbock DT, and Moore KJ. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat Immunol 11: 155-161, 2010.
58. Sumi M, Sata M, Miura S, Rye KA, Toya N, Kanaoka Y, Yanaga K, Ohki T, Saku K, and Nagai R. Reconstituted high-density lipoprotein stimulates differentiation of endothelial progenitor cells and enhances ischemia-induced angiogenesis. Arterioscler Thromb Vasc Biol 27: 813-818, 2007.
59. Sun C, Liang C, Ren Y, Zhen Y, He Z, Wang H, Tan H, Pan X, and Wu Z. Advanced glycation end products depress function of endothelial progenitor cells via p38 and ERK 1/2 mitogen-activated protein kinase pathways. Basic Res Cardiol 104: 42-49, 2009.
60. Szmitko PE, Fedak PW, Weisel RD, Stewart DJ, Kutryk MJ, and Verma S. Endothelial progenitor cells: new hope for a broken heart. Circulation 107: 3093-3100, 2003.
61. Tanaka S, Miki T, Sha S, Hirata K, Ishikawa Y, and Yokoyama M. Serum levels of thiobarbituric acid-reactive substances are associated with risk of coronary heart disease. J Atheroscler Thromb 18: 584-591, 2011.
62. Tang Y, Vater C, Jacobi A, Liebers C, Zou X, and Stiehler M. Salidroside exerts angiogenic and cytoprotective effects towards human bone marrow derived endothelial progenitor cells via Akt/mTOR/p70S6K and MAPK signaling pathways. Br J Pharmacol 171: 2440-2456, 2014.
63. Tepper OM, Galiano RD, Capla JM, Kalka C, Gagne PJ, Jacobowitz GR, Levine JP, and Gurtner GC. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 106: 2781-2786, 2002.
64. Terasaka N, Wang N, Yvan-Charvet L, and Tall AR. Highdensity lipoprotein protects macrophages from oxidized low-density lipoprotein-induced apoptosis by promoting efflux of 7-ketocholesterol via ABCG1. Proc Natl Acad Sci USA 104: 15093-15098, 2007.
65. Thorne RF, Mhaidat NM, Ralston KJ, and Burns GF. CD36 is a receptor for oxidized high density lipoprotein: implications for the development of atherosclerosis. FEBS Lett 581: 1227-1232, 2007.
66. Thum T, Fraccarollo D, Thum S, Schultheiss M, Daiber A, Wenzel P, Munzel T, Ertl G, and Bauersachs J. Differential effects of organic nitrates on endothelial progenitor cells are determined by oxidative stress. Arterioscler Thromb Vasc Biol 27: 748-754, 2007.
67. Tie G, Yan J, Yang Y, Park BD, Messina JA, Raffai RL, Nowicki PT, and Messina LM. Oxidized low-density lipoprotein induces apoptosis in endothelial progenitor cells by inactivating the phosphoinositide 3-kinase/Akt pathway. J Vasc Res 47: 519-530, 2010.
68. Triantafilou M, Gamper FG, Haston RM, Mouratis MA, Morath S, Hartung T, and Triantafilou K. Membrane sorting of toll-like receptor (TLR)-2/6 and TLR2/1 heterodimers at the cell surface determines heterotypic associations with CD36 and intracellular targeting. J Biol Chem 281: 31002-31011, 2006.
69. Walter MF, Jacob RF, Bjork RE, Jeffers B, Buch J, Mizuno Y, and Mason RP. Circulating lipid hydroperoxides predict cardiovascular events in patients with stable coronary artery disease: the PREVENT study. J Am Coll Cardiol 51: 1196-1202, 2008.
70. Wang JM, Isenberg JS, Billiar TR, and Chen AF. Thrombospondin-1/CD36 pathway contributes to bone marrowderived angiogenic cell dysfunction in type 1 diabetes via Sonic hedgehog pathway suppression. Am J Physiol Endocrinol Metab 305: E1464-E1472, 2013.
71. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Bohm M, and Nickenig G. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353: 999-1007, 2005.
72. Westvik TS, Fitzgerald TN, Muto A, Maloney SP, Pimiento JM, Fancher TT, Magri D, Westvik HH, Nishibe T, Velazquez OC, and Dardik A. Limb ischemia after iliac ligation in aged mice stimulates angiogenesis without arteriogenesis. J Vasc Surg 49: 464-473, 2009.
73. Xie S, Lee YF, Kim E, Chen LM, Ni J, Fang LY, Liu S, Lin SJ, Abe J, Berk B, Ho FM, and Chang C. TR4 nuclear receptor functions as a fatty acid sensor to modulate CD36 expression and foam cell formation. Proc Natl Acad Sci USA 106: 13353-13358, 2009.
74. Yoshida T, Komaki M, Hattori H, Negishi J, Kishida A, Morita I, and Abe M. Therapeutic angiogenesis by implantation of a capillary structure constituted of human adipose tissue microvascular endothelial cells. Arterioscler Thromb Vasc Biol 30: 1300-1306, 2010.
75. Zhou B, Ma FX, Liu PX, Fang ZH, Wang SL, Han ZB, Poon MC, and Han ZC. Impaired therapeutic vasculogenesis by transplantation of OxLDL-treated endothelial progenitor cells. J Lipid Res 48: 518-527, 2007.